ArticleBMC medicine2023

New respiratory syncytial virus immunization products in low- and middle-income countries: potential for cost-effective impact on a high burden of disease in young infants.

Padmini Srikantiah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.